Selected Balance Sheet Information

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Balance Sheet Disclosures [Text Block]

4. Selected Balance Sheet Information

 Prepaid expenses and other current assets (in thousands)

	March 31, 2016		December 31, 2015
Intrexon prepaid research and development expenses	$	307	$	643
Prepaid clinical research organizations		6,160		8,329
Prepaid insurances		224		339
Other prepaid expenses		425		208
Total	$	7,116	$	9,519

The Intrexon prepaid research and development expenses are classified as a current asset. The Company may terminate the arrangement at any time and receive a cash refund of the remaining balance minus any amounts owed to Intrexon. The Company anticipates that the majority of the prepaid will be applied to research and development expenses during 2016.

Prepaid clinical research organization expense are classified as a current asset. The Company makes payments to the clinical research organizations based on agreed upon terms that includes payments in advance of study services. The Company anticipates that the majority of the prepaid clinical research organization expenses will be applied to research and development expenses during 2016.

 

Property and equipment (in thousands)

	March 31, 2016		December 31, 2015
Computer and office equipment	$	371	$	346
Software		11		11
Leasehold improvements		242		242
		624		599
Less accumulated depreciation and amortization		(123)		(105)
Total	$	501	$	494

Accrued expenses (in thousands)

	March 31, 2016		December 31, 2015
Accrued manufacturing costs	$	2	$	-
Accrued vendor payments		388		133
Accrued clinical consulting services		556		164
Total	$	946	$	297

Accrued employee benefits (in thousands)

	March 31, 2016		December 31, 2015
Accrued bonus expense	$	355	$	-
Accrued vacation expense		248		153
Other accrued employee benefits		266		124
Total	$	869	$	277